Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

J B Chemicals & Pharmaceuticals Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 25 August 2026, 7:04 am +05:30. Financial reporting periods are shown in the tables below.

Stored share price2,409₹ per share
Reported P/E53.8Times
Book value per share259₹ per share
Reported ROCE25.4 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 25 August 2026, 7:04 am +05:30. Not a live quote.

MeasureStored figure
Market Cap38,677 Cr.
Current Price2,409
High / Low2,526/1,603
Stock P/E53.8
Book Value259
Dividend Yield0.91 %
ROCE25.4 %
ROE18.9 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
J B Chemicals & Pharmaceuticals Ltd 38,677 Cr. 2,409 2,526/1,60353.8 2590.91 %25.4 %18.9 % 1.00
Wockhardt Ltd 33,875 Cr. 2,084 2,422/1,08785.0 3040.00 %7.55 %6.11 % 5.00
Ajanta Pharma Ltd 44,789 Cr. 3,581 3,797/2,37939.5 3620.89 %34.5 %27.1 % 2.00
Glaxosmithkline Pharmaceuticals Ltd 46,973 Cr. 2,771 3,121/2,08844.6 1342.06 %61.4 %45.6 % 10.0
Gland Pharma Ltd 47,356 Cr. 2,874 3,042/1,57433.5 6560.70 %17.4 %12.8 % 1.00
Industry Average17,560.90 Cr1,250.1654.88211.240.39%26.16%16.59%6.06

All Competitor Stocks of J B Chemicals & Pharmaceuticals Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales 7628968828458621,0041,0019639491,0941,0851,065904
Expenses 599664638621664724730709723793775769703
Operating Profit 164232244223198280271255226301310296201
OPM % 21%26%28%26%23%28%27%26%24%28%29%28%22%
Other Income 568717610814151518-15
Interest 14121012962311121
Depreciation 32313234414142424643444550
Profit before tax 122194209184165240237218193272279267135
Tax % 28%27%28%27%23%26%26%25%25%25%26%26%25%
Net Profit 88142151134126177175162146202208198101
EPS in Rs 5.669.199.728.628.1311.3911.2410.459.3612.9613.2712.636.31

Last Updated: September 29, 2026, 7:40 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 27, 2026, 5:02 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales 1,0221,1441,2101,3441,4081,6431,7752,0432,4243,1493,4843,9184,148
Expenses 8749641,0041,1121,1911,3371,3971,4821,8812,4542,5872,8863,040
Operating Profit 1481802062322183063785605436968971,0321,107
OPM % 14%16%17%17%15%19%21%27%22%22%26%26%27%
Other Income -271158503741411123910373833
Interest 67115353753644126
Depreciation 283941475756666973114138171182
Profit before tax 87146212230194287349597505555752887952
Tax % 30%31%23%20%28%32%22%25%24%26%26%26%26%
Net Profit 62100163184139194272449386410553660709
EPS in Rs 3.635.929.5810.858.2712.0617.6028.9824.9326.4835.6142.3644.18
Dividend Payout % 41%118%26%5%12%21%31%28%33%34%34%37%50%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)61.29%63.00%12.88%-24.46%39.57%40.21%65.07%-14.03%6.22%34.88%19.35%7.42%
Change in YoY Net Profit Growth (%)0.00%1.71%-50.12%-37.34%64.02%0.64%24.87%-79.10%20.25%28.66%-15.53%-11.92%

J B Chemicals & Pharmaceuticals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:13%
5 Years:17%
3 Years:17%
TTM:12%
Compounded Profit Growth
10 Years:21%
5 Years:20%
3 Years:21%
TTM:17%
Stock Price CAGR
10 Years:30%
5 Years:34%
3 Years:23%
1 Year:-11%
Return on Equity
10 Years:17%
5 Years:20%
3 Years:19%
Last Year:20%

Last Updated: September 5, 2025, 8:10 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: July 3, 2026, 6:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 171717171615151515161616
Reserves 9781,1671,3471,4251,4641,4201,7942,1192,4652,9083,4184,143
Borrowings 127193492926294555572378284
Other Liabilities 365270262294286349376412495687804799
Total Liabilities 1,4871,6481,6741,7651,7921,8142,2312,6013,5473,9884,2654,962
Fixed Assets 3294406796406216516341,2771,9012,0041,9681,885
CWIP 551354171516261955766374
Investments 55247941143445740367813206388345765
Other Assets 5525945806746997438941,2931,3851,5191,8892,237
Total Assets 1,4871,6481,6741,7651,7921,8142,2312,6013,5473,9884,2654,962
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 127140201123194276315170626801902704
Cash from Investing Activity + -112-26-45-21-2824-2312-962-404-296-586
Cash from Financing Activity + -1-100-184-60-156-306-87-138357-385-580-123
Net Cash Flow 1315-284311-6-334201127-5
Free Cash Flow 56-634894153205315-529-138540783623
CFO/OP 91%94%107%75%85%97%81%56%104%104%107%87%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow56.00-63.0048.0094.00153.00205.00315.00-529.00-138.00540.00783.00623.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 848482727868717084677276
Inventory Days 120122146138145149159181178134155147
Days Payable 54637168757297979775110114
Cash Conversion Cycle 150143158142148146133153164127117109
Working Capital Days 7016387593918191122815579
ROCE %13%13%15%14%11%18%23%33%23%22%25%26%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters 53.91%53.86%53.83%53.78%53.77%53.74%53.66%47.84%47.73%47.56%47.55%48.80%
FIIs 9.53%10.05%10.35%11.06%12.17%13.63%14.64%18.30%17.77%15.31%14.88%16.33%
DIIs 18.65%18.58%18.53%18.38%17.61%16.81%16.40%18.71%19.62%22.83%23.35%21.38%
Government 0.00%0.00%0.00%0.01%0.00%0.01%0.00%0.00%0.00%0.00%0.00%0.00%
Public 17.90%17.50%17.27%16.78%16.42%15.80%15.29%15.13%14.87%14.31%14.21%13.48%
No. of Shareholders 55,96560,81763,23063,89266,95362,74362,08163,94870,06471,95769,33874,043
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Kotak Midcap Fund 4,816,878 1.53 900.52N/AN/AN/A
Axis Small Cap Fund 2,984,782 2.19 558.012,207,4752025-12-08 05:55:3735.21%
Canara Robeco Small Cap Fund 1,353,805 2 253.09790,0682025-12-08 05:55:3771.35%
Franklin India Small Cap Fund 1,316,741 1.93 246.161,448,7232026-02-22 13:50:45-9.11%
Axis ELSS Tax Saver Fund 1,087,630 0.62 203.33N/AN/AN/A
Nippon India Pharma Fund 999,649 2.37 186.881,486,8682025-12-08 04:19:42-32.77%
Nippon India Small Cap Fund 991,107 0.28 185.29937,8722025-12-08 05:55:375.68%
Axis Midcap Fund 984,875 0.6 184.12N/AN/AN/A
Nippon India Multi Cap Fund 898,827 0.34 168.04949,8342025-12-15 04:02:53-5.37%
Franklin India Large & Mid Cap Fund 767,185 4.08 143.43N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.002.002.002.00
Basic EPS (Rs.) 42.4535.6653.0049.8657.96
Diluted EPS (Rs.) 41.5634.8552.3449.8657.96
Cash EPS (Rs.) 53.3644.5267.7759.3566.92
Book Value[Excl.RevalReserv]/Share (Rs.) 220.54188.36320.55276.73234.65
Book Value[Incl.RevalReserv]/Share (Rs.) 220.54188.36320.55276.73234.65
Revenue From Operations / Share (Rs.) 251.67224.50407.00313.69264.29
PBDIT / Share (Rs.) 68.7460.1991.2075.4087.06
PBIT / Share (Rs.) 57.7651.2876.4266.0078.17
PBT / Share (Rs.) 57.0048.4271.7665.3377.23
Net Profit / Share (Rs.) 42.3735.6152.9949.9558.04
NP After MI And SOA / Share (Rs.) 42.3735.6152.9749.8657.96
PBDIT Margin (%) 27.3126.8122.4024.0332.93
PBIT Margin (%) 22.9422.8418.7721.0329.57
PBT Margin (%) 22.6421.5617.6320.8229.22
Net Profit Margin (%) 16.8315.8613.0115.9221.95
NP After MI And SOA Margin (%) 16.8315.8613.0115.8921.93
Return on Networth / Equity (%) 19.2118.9016.5218.0524.75
Return on Capital Employeed (%) 24.6925.4519.7122.9331.91
Return On Assets (%) 15.4313.8311.5314.7720.01
Long Term Debt / Equity (X) 0.000.010.150.000.00
Total Debt / Equity (X) 0.000.120.220.010.01
Asset Turnover Ratio (%) 0.940.921.020.910.94
Current Ratio (X) 3.042.132.763.324.50
Quick Ratio (X) 2.201.561.982.253.49
Inventory Turnover Ratio (X) 7.601.751.871.731.96
Dividend Payout Ratio (NP) (%) 35.9328.4031.1333.0916.38
Dividend Payout Ratio (CP) (%) 28.5322.7224.3327.8414.21
Earning Retention Ratio (%) 64.0771.6068.8766.9183.62
Cash Earning Retention Ratio (%) 71.4777.2875.6772.1685.79
Interest Coverage Ratio (X) 91.2421.0719.57113.7992.91
Interest Coverage Ratio (Post Tax) (X) 57.2413.4712.3776.3962.94
Enterprise Value (Cr.) 25138.2825860.2415719.7612145.749693.57
EV / Net Operating Revenue (X) 6.427.424.995.014.75
EV / EBITDA (X) 23.4927.6822.2820.8414.41
MarketCap / Net Operating Revenue (X) 6.457.354.845.024.74
Retention Ratios (%) 64.0671.5968.8666.9083.61
Price / BV (X) 7.368.766.155.705.35
Price / Net Operating Revenue (X) 6.457.354.845.024.74
EarningsYield 0.020.020.020.030.04
Advertisements
Explore Industry-wise Company financial data